NUVL250117P90000
- 6.70
- 0.000.00%
Nuvalent Newsroom
Jefferies Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $137
Nuvalent Insider Sold Shares Worth $2,338,436, According to a Recent SEC Filing
Top Gap Ups and Downs on Thursday: CIEN, WBD, ADBE and More
Express News | Form 144 | Nuvalent(NUVL.US) Insider Proposes to Sell 12.7 Million in Common Stocks
Express News | Form 144 | Nuvalent(NUVL.US) Insider Proposes to Sell 104.31 Million in Common Stocks
Nuvalent Elects Grant Bogle as Independent Director
Express News | Nuvalent Appoints Grant Bogle to Board of Directors
Barclays Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $100
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference
J.P. Morgan Reaffirms Their Buy Rating on Nuvalent (NUVL)
Express News | Nuvalent Inc : JP Morgan Cuts Target Price to $121 From $125
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely
Nuvalent's Promising ALK and ROS1 Programs Drive Buy Rating Amid Strong Financial Position and Upcoming Trials
TD Cowen Maintains Nuvalent(NUVL.US) With Buy Rating
BMO Capital Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $134
Stifel Maintains Nuvalent(NUVL.US) With Buy Rating, Cuts Target Price to $132
Nuvalent Is Maintained at Outperform by BMO Capital
Nuvalent Analyst Ratings
A Quick Look at Today's Ratings for Nuvalent(NUVL.US), With a Forecast Between $100 to $134
Nuvalent Reports Q3 EPS ($1.28), Consensus (94c)